Jeffrey J. Scherman - May 9, 2023 Form 4 Insider Report for Bright Health Group Inc. (BHG)

Role
Chief Accounting Officer
Signature
/s/ Eric Halverson for Jeffrey J. Scherman, Attorney-in-Fact
Stock symbol
BHG
Transactions as of
May 9, 2023
Transactions value $
-$2,159
Form type
4
Date filed
5/11/2023, 07:32 PM
Previous filing
Mar 15, 2023
Next filing
Mar 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHG Common Stock Options Exercise +27.4K +47.32% 85.3K May 9, 2023 Direct F1
transaction BHG Common Stock Sale -$2.16K -5.84K -6.85% $0.37* 79.4K May 10, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHG Restricted Stock Units Options Exercise $0 +27.4K +99.99% $0.00 54.8K May 9, 2023 Common Stock 27.4K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.35 to $0.39 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The restricted stock units vest in three equal annual installments beginning on May 9, 2023.